Accelerated atherosclerosis in a patient with post-BMT nephropathy

被引：2
|
作者：
Akasheh, M [1 ]
Priyanath, A [1 ]
Pello, N [1 ]
Watry, P [1 ]
Vesole, D [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷 / 02期
关键词：
D O I：
10.1038/sj.bmt.1701544
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [31] Adenovirus virus (ADV) infections and disease post-BMT in Australia and New Zealand (ANZ): A prospective survey.
    Bleakley, M
    Shaw, PJ
    Nivison-Smith, I
    BLOOD, 2001, 98 (11) : 393A - 393A
  • [32] Successful lung transplantation for post-bmt bronchiolitis obliterans and lipoid pneumonia associated with atypical mycobacterium and aspergillosis infection
    Au, W. Y.
    Lie, A. K.
    Cbeng, V. C. C.
    Cheng, L. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (08): : 870 - 872
  • [33] Might hyperhomocysteinemia contribute to the accelerated atherosclerosis of diabetics patients with nephropathy
    Chico, A
    Cordoba, A
    Blanco, F
    Rigla, M
    Arcelus, R
    Carrascosa, C
    Ordonez, J
    Perez, A
    DIABETOLOGIA, 1996, 39 : 1074 - 1074
  • [34] Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT
    Godder, K
    Pati, A
    Abhyankar, S
    Gee, AP
    Parrish, R
    Lee, C
    HensleeDowney, PJ
    BONE MARROW TRANSPLANTATION, 1996, 17 (01) : 49 - 53
  • [35] Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naive Settings
    Garcia, Jacqueline S.
    Flamand, Yael
    Tomlinson, Benjamin K.
    Keng, Michael
    Mendez, Lourdes M.
    Khaled, Samer
    Bashey, Asad
    Brunner, Andrew M.
    Savell, Alexandra
    Neuberg, Donna
    Galinsky, Ilene
    Luskin, Marlise R.
    Steensma, David P.
    Wadleigh, Martha
    Winer, Eric S.
    Avigan, David E.
    Cullen, Nicole
    Rodig, Scott
    Penter, Livius
    Lindsley, R. Coleman
    Andrews, Stephanie
    Davids, Matthew S.
    Wu, Catherine J.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Soiffer, Robert J.
    BLOOD, 2020, 136
  • [36] STAGE-IV NEURO-BLASTOMA ALIVE PROGRESSION FREE 17 MONTHS POST-BMT ARE NOT CURED
    PHILIP, T
    HARTMANN, O
    AUGUST, C
    DINI, G
    BEAUJEAN, F
    ZUCKER, JM
    BERNARD, JL
    GARAVENTA, A
    LASSET, C
    CHAUVIN, F
    EVANS, A
    BONE MARROW TRANSPLANTATION, 1988, 3 : 86 - 86
  • [37] PCR monitoring of sequential BAL samples to identify patients at high risk to develop invasive pulmonary aspergillosis post-BMT
    Einsele, H
    Hebart, H
    Loffler, H
    Rothenhofer, I
    Quabeck, K
    Schafer, U
    Schumacher, U
    Kanz, L
    BLOOD, 1996, 88 (10) : 1691 - 1691
  • [38] IL-7 ENHANCES T-LYMPHOCYTE RECONSTITUTION POST-BMT BY STIMULATING THYMOPOIESIS FROM IMMATURE PROGENITORS
    BOLOTIN, E
    SMITH, S
    SMOGORZEWSKA, EM
    WIDMER, M
    WEINBERG, K
    BLOOD, 1994, 84 (10) : A345 - A345
  • [39] Early post-BMT liver function in children with acute leukemia conditioned for allo-BMT with busulfan-containing and with FTBI-containing preparative regimens
    Wachowiak, J
    Boruczkowski, D
    Malicki, J
    Chobot-Musialkiewicz, U
    BONE MARROW TRANSPLANTATION, 1998, 22 : S96 - S99
  • [40] Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse
    Moravcová, J
    Muchová, S
    Lukásová, M
    Klamová, H
    Brezinová, J
    Gasová, Z
    BONE MARROW TRANSPLANTATION, 1999, 23 (08) : 857 - 859
12345